GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Clinical trial NCT05183243 · UNKNOWN

Trial details

NCT number: NCT05183243
Sponsor: Suzhou Genhouse Bio Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Non-Small Cell Lung Cancer Pancreatic Cancer Colorectal Cancer Head and Neck Neoplasm

Start date: 2022-02-20
Primary completion: 2024-12-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.